BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9071918)

  • 21. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma.
    Brewster AM; Lee JJ; Clayman GL; Clifford JL; Reyes MJ; Zhou X; Sabichi AL; Strom SS; Collins R; Meyers CA; Lippman SM
    J Clin Oncol; 2007 May; 25(15):1974-8. PubMed ID: 17513803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 13-cis retinoic acid in combination with interferon-alpha enhances radiation sensitivity of human squamous cell carcinoma cells of the oral cavity.
    Bläse M; Zaruba MM; Santo-Hoeltje L; Bamberg M; Hoffmann W; Rodemann HP
    Strahlenther Onkol; 1999 Nov; 175(11):563-8. PubMed ID: 10584127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot trial of combination cisplatin, 5-fluorouracil and interferon-alpha in the treatment of advanced esophageal carcinoma.
    Bazarbashi S; Rahal M; Raja MA; El Weshi A; Pai C; Ezzat A; Ajarim D; Memon M; Al Fadda M
    Chemotherapy; 2002 Sep; 48(4):211-6. PubMed ID: 12218269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active cancer therapy combining 13-cis-retinoic acid with interferon-alpha.
    Dmitrovsky E; Bosl GJ
    J Natl Cancer Inst; 1992 Feb; 84(4):218-9. PubMed ID: 1734081
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.
    Shin DM; Glisson BS; Khuri FR; Clifford JL; Clayman G; Benner SE; Forastiere AA; Ginsberg L; Liu D; Lee JJ; Myers J; Goepfert H; Lotan R; Hong WK; Lippman SM
    J Clin Oncol; 2002 Jan; 20(2):364-70. PubMed ID: 11786562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus.
    Wadler S; Haynes H; Beitler JJ; Hu X; Fell S; Camacho M; Levine B; Wiernik PH
    Cancer; 1996 Jul; 78(1):30-4. PubMed ID: 8646722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
    Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinoma.
    Pazdur R; Bready B; Ajani JA; Abbruzzese JL; Markowitz A; Sugarman S; Jones D; Levin B
    Am J Clin Oncol; 1995 Oct; 18(5):436-8. PubMed ID: 7572763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 13-cis retinoic acid and interferon alfa-2a in the treatment of metastatic renal cell carcinoma.
    Casali A; Sega FM; Casali M; Serrone L; Terzoli E
    J Exp Clin Cancer Res; 1998 Jun; 17(2):227-9. PubMed ID: 9700585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha.
    Hoffmann W; Bläse MA; Santo-Hoeltje L; Herskind C; Bamberg M; Rodemann HP
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):991-8. PubMed ID: 10571207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [13-cis retinoic acid and interferon-alfa-2a as palliative therapy in pretreated, recurrent squamous epithelial carcinoma of the cervix uteri and vulva].
    Römisch M; Meier W; Kimmig R; Hepp H
    Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):520-4. PubMed ID: 9036064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer.
    Rinaldi DA; Lippman SM; Burris HA; Chou C; Von Hoff DD; Hong WK
    Anticancer Drugs; 1993 Feb; 4(1):33-6. PubMed ID: 8457712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Searching for a standard.
    Cohen EE; Vokes EE
    J Clin Oncol; 2002 Jan; 20(2):359-61. PubMed ID: 11786560
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of multiple lesions of Bowen disease with isotretinoin and interferon alfa. Efficacy of combination chemotherapy.
    Gordon KB; Roenigk HH; Gendleman M
    Arch Dermatol; 1997 Jun; 133(6):691-3. PubMed ID: 9197821
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
    Arnold A; Ayoub J; Douglas L; Hoogendoorn P; Skingley L; Gelmon K; Hirsh V; Eisenhauer E
    J Natl Cancer Inst; 1994 Feb; 86(4):306-9. PubMed ID: 8158687
    [No Abstract]   [Full Text] [Related]  

  • 36. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
    Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
    Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma.
    Dhingra K; Papadopoulos N; Lippman S; Lotan R; Legha SS
    Invest New Drugs; 1993 Feb; 11(1):39-43. PubMed ID: 8349434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
    Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ
    J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoic acid and interferon in human cancer: mechanistic and clinical studies.
    Moore DM; Kalvakolanu DV; Lippman SM; Kavanagh JJ; Hong WK; Borden EC; Paredes-Espinoza M; Krakoff IH
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):31-7. PubMed ID: 7831583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma.
    Urba SG; Forastiere AA; Wolf GT; Amrein PC
    Cancer; 1993 Apr; 71(7):2326-31. PubMed ID: 8453554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.